Author:
Stürzl M.,Ascherl G.,Tschachler E.,Monini P.,Ensoli B.,Hohenadl C.
Publisher
Springer Berlin Heidelberg
Reference48 articles.
1. Aboulafìa D, Miles SA, Saks SR, Mitsuyasu RT (1989) Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi’s sarcoma. J Acquir Immune Defic Syndr 2: 54–58
2. Albrecht H, Stellbrink HJ, Gross G, Berg B, Helmchen U, Mensing H (1994) Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi’s sarcoma in an AIDS patient. Clin Investig 72: 1041–1047
3. Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, Lennette ET, Levy JA (1995) Herpes-like sequences in HIV-infected and uninfected Kaposi’s sarcoma patients. Science 268: 582–583
4. Ascherl G, Hohenadl C, Schatz O, Schumay E, Bogner J, Eckhart L, Tschachler E, Monini P, Ensoli B, Stürzl M (1999) Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T-cells: implications for acquired immunodeficiency syndrome- associated vasculopathy. Blood 93: 1–11
5. Ballard HS (1985) Disseminated Kaposi’s sarcoma without lymphocyte abnormalities. Arch Intern Med 145: 547